An observational study in Deep Vein Thrombosis, sponsored by Klinikum Arnsberg. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-02-23.
Sponsored by Klinikum Arnsberg · Observational
The aim of the study is to evaluate the safety and performance of the ClotTriever catheter in the treatment of patients with symptomatic iliofemoral deep vein thrombosis (DVT)
Data from patients in whom the ClotTriever catheter was used for treatment of iliofemoral DVT was retrospectively collected for up to 6 months after the procedure for evaluation of safety and effectiveness.
1,506 studies on the registry are indexed under Thrombosis; 238 are open to participants now.
This study's enrollment of 25 is below the median of 213 across 586 observational studies indexed under Thrombosis.
Browse Thrombosis studies →Klinikum Arnsberg is the lead sponsor of 5 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients treated in the vascular center of the clinic
Exclusion Criteria:
Treatment of iliofemoral deep vein thrombosis with the ClotTriever catheter
Procedural success
Restauration of inflow in the treated vein
Time frame: directly after treatment of the vein (Day 0)
Incidence of ClotTriever related major adverse events (MAE)
MAEs defined as death, major amputation or any clinically driven target lesion revascularisation
Time frame: 1 month
Number of lesions with at least Society Interventional Radiology (SIR) Grad II Lyse (50-95% thrombus removal)
Society Interventional Radiology (SIR) Grad II Lyse (50-95 % thrombus removal) or greater at the end of the procedure including adjunctive treatments
Time frame: directly after treatment of the vein (Day 0)
Vilallta score
Score for post thrombotic syndrome (PTS) assessing 5 subjective symptoms (pain, cramps, heaviness, paresthesia, pruritus) and 6 clinical signs (pretibial edema, skin induration, hyperpigmentation, redness, venous ectasia, pain on calf compression) with a 4-point scale from 0 (not present) to 3 (severe).
Time frame: Day 0, month 1 and 6
Venous clinical severity score (VCSS)
Score of 10 parameters each assessed by severity 0-3.
Time frame: Day 0, month 1 and 6
Plan to share: No — It is not planned to share IPD
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Klinikum Arnsberg